(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONCOEXTRA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ONCOEXTRA

ST13

US500000097744739

Class

44

Filing

97744739

Registration

7311880

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

06/02/2026

Trademark type

Word

Nice classes

44

Filing date

01/06/2023

Registration date

02/20/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/20/2024

Last transaction

06/02/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/06/2023

First use in commerce

02/06/2023

Drawing code

4

Owner type

03

Owner location

Madison, WI, US

Examiner

FARRAG, SHERIF G

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Genomic Health, Inc.
Genomic Health, Inc.

Representatives

Sana Hakim K&L Gates LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical testing for diagnostic and prognostic purposes and therapy selection in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Providing medical information to medical professionalsoncologists and treating physicians for cancer patientsin the form of reports in the field of cancer diagnostics and prognostics; Medical testing servicesgenetic testing and next generation sequencing test for diagnosis and treatment of cancer

Publications

History of USPTO decisions and trademark events.

23 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/01/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/09/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/09/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/09/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/09/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/09/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/22/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/20/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/20/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/18/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/17/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/04/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/03/2024

IUAF

USE AMENDMENT FILED

12/12/2023

EISU

TEAS STATEMENT OF USE RECEIVED

12/12/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/28/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/03/2023

PUBO

PUBLISHED FOR OPPOSITION

10/03/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/13/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/30/2023

DOCK

ASSIGNED TO EXAMINER

08/08/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/30/2023

NWAP

NEW APPLICATION ENTERED

01/10/2023

Continuous trademark protection

Get notified about every new filing that threatens ONCOEXTRA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.